CLBS - Caladrius Biosciences Inc
Close
6.25
-2.750 -44.000%
Share volume: 0
Last Updated: Thu 15 Sep 2022 10:00:00 PM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$9.00
-2.75
-30.56%
Summary score
37%
Profitability
35%
Dept financing
25%
Liquidity
48%
Performance
40%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.58%
Return on assets
-12.77%
Return on sales
-84.03%
Return on invested capital
10.12%
Total debt ratio
25.16%
Debt ratio change over timeo
-1.02%
Current Ratio
5.75%
Quick Ratio
0%
Cash Position Ratio
2.7%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.71%
Return on assets
-17.24%
Return on sales
0%
Return on invested capital
16.96%
Total debt ratio
18.88%
Debt ratio change over timeo
-0.83%
Current Ratio
6.13%
Quick Ratio
0%
Cash Position Ratio
4.16%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
19.51%
Return on assets
-13.32%
Return on sales
0%
Return on invested capital
-251.35%
Total debt ratio
9.79%
Debt ratio change over time
-0.91%
Current Ratio
10.52%
Quick Ratio
0%
Cash Position Ratio
7.67%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-101.85%
Return on assets
-105.8%
Return on sales
44.77%
Return on invested capital
-0.91%
Total debt ratio
-102.27%
Debt ratio change over time
-1.02%
Current Ratio
4.98%
Quick Ratio
0%
Cash Position Ratio
1.79%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | CLBS | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -9.58% | -4.61% | -11.83% | 0% |
Return on assets | -12.77% | -4.6% | -10.3% | 0% |
Return on sales | -84.03% | -37.29% | 0% | 0% |
Return on invested capital | 10.12% | 265.33% | -27.14% | 0% |
Profitability | 1% | 25% | 25% | 50% |
Total debt ratio | 25.16% | 18.22% | 14.3% | 0% |
Debt ratio change over time | -1.02% | -1.66% | -1.56% | 0% |
Dept financing | 25% | 18% | 14% | 25% |
Current Ratio | 6.13% | 4.65% | 5.1% | 0% |
Quick Ratio | 0% | 4.32% | 0% | 0% |
Cash Position Ratio | 4.16% | 0.81% | 2.5% | 0% |
Liquididy | 45% | 46% | 38% | 0% |
Short-term ratios | CLBS | SGEN | NK | SRNG |
---|---|---|---|---|
Return on equity | -11.71% | -3.62% | -13.55% | 0% |
Return on assets | -17.24% | -3.93% | -11.56% | 0% |
Return on sales | 0% | -34.27% | 0% | 0% |
Return on invested capital | 16.96% | -9.88% | -24.84% | 0% |
Profitability | 50% | 0% | 0% | 50% |
Total debt ratio | 18.88% | 15.47% | 15.89% | 0% |
Debt ratio change over time | -0.83% | -0.59% | -1.72% | 0% |
Dept financing | 25% | 20% | 21% | 25% |
Current Ratio | 6.13% | 4.65% | 5.1% | 0% |
Quick Ratio | 0% | 4.32% | 0% | 0% |
Cash Position Ratio | 4.16% | 0.81% | 2.5% | 0% |
Liquididy | 50% | 49% | 36% | 0% |